DelMar Pharmaceuticals Inc. (DMPI) Slipped -9.12% or -0.04 To Price $0.37 On Friday

DelMar Pharmaceuticals Inc. (DMPI) slipped -9.12% or -0.04 to $0.37. It is close to 61538 shares traded, which is 70.15% compare to the average total volume 87722. The market cap of DMPI is $8.35 million. The year to date change is 6.84%. The 52 week price range is from $0.31 to $1.38. Price of DMPI have changed 20.81% during last week. It have changed 19.08% over last month, -27.30% over last 3 months, -24.61% over last 6 months and -70.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DMPI is 0.42. It is 13.51% above current price. The 200-day Moving Averages for DMPI is 0.64. It is 72.97% above current price. The 52-week High is 1.38. It is 272.97% from the current price. The 52-week Low is 0.31. It is -16.22% from current price.

There are some statistics of DMPI. It is has market cap $8.35 million. The share outstanding is 22.56 million. The average volume is 87722. The percent of top 15 Institution holding is 0.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DMPI is 653.29%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DMPI is 125.93%.


Share this post